ZA9510995B - Bone mass anabolic composition - Google Patents

Bone mass anabolic composition

Info

Publication number
ZA9510995B
ZA9510995B ZA9510995A ZA9510995A ZA9510995B ZA 9510995 B ZA9510995 B ZA 9510995B ZA 9510995 A ZA9510995 A ZA 9510995A ZA 9510995 A ZA9510995 A ZA 9510995A ZA 9510995 B ZA9510995 B ZA 9510995B
Authority
ZA
South Africa
Prior art keywords
bone mass
anabolic composition
anabolic
composition
bone
Prior art date
Application number
ZA9510995A
Other languages
English (en)
Inventor
Socrates Papapoulos
Jose Luis Ferretti
Rafael Labriola
Nelida Mondelo
Emilio J A Roldan
Original Assignee
Gador Sa
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gador Sa, Univ Leiden filed Critical Gador Sa
Publication of ZA9510995B publication Critical patent/ZA9510995B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9510995A 1994-12-28 1995-12-28 Bone mass anabolic composition ZA9510995B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94120799 1994-12-28

Publications (1)

Publication Number Publication Date
ZA9510995B true ZA9510995B (en) 1997-06-30

Family

ID=8216571

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9510995A ZA9510995B (en) 1994-12-28 1995-12-28 Bone mass anabolic composition

Country Status (11)

Country Link
EP (1) EP0800397B1 (xx)
JP (1) JP3796693B2 (xx)
KR (1) KR100385697B1 (xx)
AR (1) AR000555A1 (xx)
AU (1) AU701258B2 (xx)
BR (1) BR9510123A (xx)
CA (1) CA2208714C (xx)
DE (1) DE69534923T2 (xx)
ES (1) ES2262145T3 (xx)
WO (1) WO1996019998A1 (xx)
ZA (1) ZA9510995B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753523A1 (en) * 1995-07-10 1997-01-15 Gador S.A. Amino-substituted bisphosphonic acids
DE19719680A1 (de) * 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
ES2231919T3 (es) * 1997-07-15 2005-05-16 Gador S.A. Forma cristalina de sal monosodica monohidrato del acido n,n-dimetil-3-amino-1-hidroxipropano-1,1-difosfonico.
AR013994A1 (es) * 1998-10-30 2001-01-31 Gador Sa Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes.
US6416737B1 (en) * 1998-11-19 2002-07-09 Board Of Trustees Of The University Of Arkansas Increasing bone strength with selected bisphosphonates
BRPI0116865B8 (pt) 2001-01-23 2021-05-25 Gador Sa composição compreendendo bisfosfonatos para prevenção e/ou tratamento de doenças metabólicas dos ossos, processo para preparar tal composição e uso desta
BR0308901A (pt) 2002-05-10 2005-01-04 Hoffmann La Roche ácidos bisfosfÈnicos para tratamento e prevenção de osteoporose
CA2689504A1 (en) * 2007-06-19 2008-12-24 Albemarle Corporation Processes for manufacturing bisphosphonic acids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587956T2 (de) * 1984-04-30 1995-05-24 Procter & Gamble Ausrüstung für die Verwendung bei der Behandlung von Osteoporose.
JP3727332B2 (ja) * 1991-02-26 2005-12-14 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド 骨粗鬆症の治療方法
SK74594A3 (en) * 1991-12-17 1995-01-12 Procter & Gamble Pharma Treatment for treating of osteoporosis
AU659329B2 (en) * 1992-06-30 1995-05-11 Procter & Gamble Pharmaceuticals, Inc. Use of phosphonates for the treatment of osteoporosis
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis

Also Published As

Publication number Publication date
AU4434796A (en) 1996-07-19
WO1996019998A1 (en) 1996-07-04
CA2208714C (en) 2003-10-21
AR000555A1 (es) 1997-07-10
AU701258B2 (en) 1999-01-21
EP0800397A1 (en) 1997-10-15
DE69534923T2 (de) 2006-11-23
JPH11502506A (ja) 1999-03-02
BR9510123A (pt) 1997-12-30
DE69534923D1 (de) 2006-05-18
JP3796693B2 (ja) 2006-07-12
ES2262145T3 (es) 2006-11-16
EP0800397B1 (en) 2006-04-05
CA2208714A1 (en) 1996-07-04
KR100385697B1 (ko) 2003-08-21

Similar Documents

Publication Publication Date Title
ZA951012B (en) Composition
EG20929A (en) Cleasing compositions
GB9408545D0 (en) Compositions
HUT78017A (hu) Fogápoló készítmény
EP0768089A4 (en) HEALTH PREPARATION
HU9600207D0 (en) Vaccine compositions
GB9425941D0 (en) Oral composition
GB9409543D0 (en) Compositions
ZA9510995B (en) Bone mass anabolic composition
ZA954709B (en) Mineral-fiber compositions
GB2290299B (en) Anti-lubricant compositions
GB9415810D0 (en) Composition
GB9416768D0 (en) Compositions
EP0705632A3 (en) Polyisobutylene-polydimethyl siloxane compositions terminated with a 2-methylpropenyl
GB9410139D0 (en) Hebicidal composition
GB9416767D0 (en) Compositions
HU9401077D0 (en) David-star composition
PL304514A1 (en) Resin-asphalt composition
GB9405023D0 (en) Composition
GB9407734D0 (en) Composition
GB9408548D0 (en) Composition
GB9412943D0 (en) Composition
GB9417808D0 (en) Composition
GB9420354D0 (en) Composition
GB9425980D0 (en) Vaccine compositions